SCLERODERMA, SYSTEMIC
Clinical trials for SCLERODERMA, SYSTEMIC explained in plain language.
Never miss a new study
Get alerted when new SCLERODERMA, SYSTEMIC trials appear
Sign up with your email to follow new studies for SCLERODERMA, SYSTEMIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could ifetroban ease scleroderma lung damage?
Disease control OngoingThis study tests an experimental drug called ifetroban in people with a severe form of scleroderma (diffuse cutaneous systemic sclerosis) or scleroderma-related high blood pressure in the lungs. The goal is to see if the drug is safe and can improve lung function. About 34 adults…
Matched conditions: SCLERODERMA, SYSTEMIC
Phase: PHASE2 • Sponsor: Cumberland Pharmaceuticals • Aim: Disease control
Last updated May 05, 2026 11:55 UTC
-
Light therapy shows promise for tight skin diseases
Symptom relief OngoingThis study looks at whether 30 sessions of UVA-1 light therapy can improve how people with scleroderma, morphea, or skin-related graft-versus-host disease feel and function in daily life. About 30 adults will receive the treatment and report their symptoms using questionnaires. T…
Matched conditions: SCLERODERMA, SYSTEMIC
Phase: NA • Sponsor: University of Utah • Aim: Symptom relief
Last updated May 18, 2026 12:01 UTC